Sanofi

News

Sanofi agrees on monetary settlement for bribery charges

Sanofi has agreed on a civil settlement with the US Securities and Exchange Commission (SEC) to resolve charges related to…

News

Sanofi’s Cablivi receives EC approval to treat rare blood disorder

The European Commission (EC) has granted marketing authorisation for Sanofi’s Cablivi (caplacizumab) indicated to treat adults with acquired thrombotic thrombocytopenic…

News

Sanofi and Revolution Medicines partner to develop cancer treatments

Sanofi has formed an alliance with US-based drug discovery company Revolution Medicines to develop and commercialise potential treatments for non-small…

News

Sanofi integrates infectious disease unit into Evotec

Sanofi has completed the strategic integration of its infectious disease unit, including most of the associated research portfolio, into German…